Many problems may arise within the gastrointestinal tract of patients with cystic fibrosis. We report a new cause of subacute intestinal obstruction due to a fibrotic stricture ofthe ascending colon in a child with cystic fibrosis. Treatment was with a right hemicolectomy. There has been no recurrence after nine months follow-up. Recent similar cases suggest that this new pathology is linked to the use of enteric-coated high-strength pancreatin microspheres.
Summary
Many problems may arise within the gastrointestinal tract of patients with cystic fibrosis. We report a new cause of subacute intestinal obstruction due to a fibrotic stricture ofthe ascending colon in a child with cystic fibrosis. Treatment was with a right hemicolectomy. There has been no recurrence after nine months follow-up. Recent similar cases suggest that this new pathology is linked to the use of enteric-coated high-strength pancreatin microspheres. Keywords At age of 2 years and 9 months, he developed an insidious fall in appetite associated with intermittent colicky abdominal pain. After several weeks this was followed by nocturnal vomiting, less frequent bowel actions, which were of normal consistency and his weight fell from the 50k" to the 25th centile. These symptoms failed to respond to either laxatives or an increased enzyme intake (25 capsules per day). Other medications included budesonide via Nebuhaler (800 fg/day) for wheezing and several courses of co-amoxiclav (amoxycillin + clavulanic acid) for respiratory tract infections.
On examination, he was lethargic and mildly dehydrated (< 5%). His abdomen was distended with an ill-defined tender mass in the right iliac fossa. Bowel sounds were normal and no faeces or abnormalities were found on rectal examination. There was no clinical evidence of active pulmonary disease. Investigations revealed haemoglobin 13.7 g/dl, erythrocyte sedimentation rate 4 mm/h and leucocyte count 13.4 x 109 /1, which were all within normal range for his age. An abdominal radiograph showed dilated loops of small bowel (figure 1) but no fluid levels and no features to suggest distal intestinal obstruction syndrome. An abdominal ultrasound identified thickened bowel wall (7 mm) in the region of the caecum and a barium enema demonstrated a featureless transverse colon leading to a narrow and irregular ascending colon which was slow to fill with contrast (figure 2).
Conservative management failed so he underwent laparotomy. A thickened ileocaecal valve, caecum and proximal 8 cm of ascending colon were resected and a primary ileocolic anastomosis was performed. The bowel was not discoloured but the lumen was narrowed by concentric thickening of the wall. The mucosa had a mild cobblestone appearance without ulceration (figure 3) and the mesentery was normal.
Histology showed characteristic changes of cystic fibrosis in the mucosa, especially in the small bowel (figure 4). The thickening and cobblestone appearance were caused by extensive submucosal fibrosis which reached the line of resection. Fibrosis was less marked in the mucosa and serosa. The muscularis propria was relatively intact. There was evidence of low-grade inflammation confined to the mucosa (figure 5). Granulomata were not seen and stains for amyloid and haemosiderin were negative. Blood vessels and lymph nodes were normal. The appendix contained abundant mucus but was otherwise normal.
His postoperative course was uncomplicated. His appetite improved and his bowel frequency returned to normal. Nine months later he remained well with no abdominal symptoms and is thriving. Crohn's disease, both of which are more common in children with cystic fibrosis than in the general population. Other considered possibilities included a retrocolic appendix mass partly suppressed by the co-amoxiclav, ileocaecal tuberculosis, or a tumour, but these were excluded at operation and by histology.
Generalised nine years. There were no ulcers, fissures, transmural inflammation or granulomas which are classical histological features of Crohn's disease. Similarly, the short history, the normal mesentery, erythrocyte sedimentation rate and haemoglobin, all make inflammatory bowel disease unlikely.
Pseudotumoral thickening of the ascending colon with similar radiographic findings has been reported in an adult with cystic fibrosis7 but no histological features were described. However, a recent report describes five cases of colonic strictures in boys with cystic fibrosis who had taken high-strength pancreatic enzymes for 12-15 months.2 The pathological changes were considered to be the result of either pressure-induced ischaemia from an intra-luminal faecal mass or direct toxicity.
The authors favoured the former mechanism and postulated that the new preparations lower the lipid content of mucus and faecal material encouraging its dehydration, so leading to increased viscosity and accumulation in the colon.
Oral mucosal irritation with contact bleeding and peri-anal soreness has been associated with the use of pancreatic enzymes.8 Therefore, a similar chronic reaction due to inappropriate enzyme activity in the ascending colon may account for the findings in this case. Indeed, stasis of faecal material in the ileocolic region is common in cystic fibrosis and we have observed intact enzyme microspheres in stools of some young patients despite the in vitro reports of rapid dissolution of enteric-coated pancreatin microspheres.9 However, any mechanism involving, or association with, high-strength pancreatin must remain speculative. Our patient remained on high-strength enzymes for 7 months after operation when the possibility of adverse reaction was identified. He is now taking standard strength preparations and ultrasound scan has revealed no evidence of further stricture, although his transverse colon is thickened (3.4 mm).
There is no doubt that the introduction of pancreatic enzyme supplements has contributed to the improved nutritional status and increased survival of patients with cystic fibrosis. However, patients frequently exceed the recommended dose, tailored according to abdominal symptoms, stool consistency, and odour. The high-strength enzyme capsules have been shown to improve the coefficient of fat absorption and enable patients to reduce capsule intake significantly, but ultimately patients tend to take a higher total daily dose of enzyme units.
At present, no colonic strictures have been reported in association with standard strength pancreatin preparations. It seems appropriate for patients with cystic fibrosis to change back to the standard preparations and to adjust doses to the minimum required for adequate fat absorption unless there are good reasons for persisting with the high-strength preparation. Further investigation is required to determine the mechanism by which fibrosis may be provoked. It is not clear why there is a male predominance. In Germany, where high-dose Learning points * distal intestinal obstruction occurs in 15% of patients with cystic fibrosis * enteric-coated high-strength pancreatin microspheres have been linked with the development offibrotic strictures of the ascending colon enzyme preparations have been used since 1986, there are no known cases, but dosing is conservative, seldom exceeding 40000 U lipase/kg body weight daily.'0 One worry is that stricture may represent one end of a spectrum of fibrosis whereas less severe forms could give rise to reduced gut motility, as described in small bowel fibrosis. Colonic strictures should be added to the list of differential diagnoses in patients with cystic fibrosis presenting with abdominal pain and vomiting. Investigation by abdominal radiography, abdominal ultrasonography and possibly barium enema to look for bowel wall thickening and lumenal narrowing should be considered in such circumstances.
